PO-148: Hypofractionated radiotherapy for head and neck cancer patients unfit for standard treatment. (March 2017) - Desideri, I.; Bonomo, P.; Ciabatti, C.; Muntoni, C.; Lo Russo, M.; Loi, M.; Greto, D.; Meattini, I.; Livi, L.